RADIOLOGY AND ONCOLOGY CONGRESSES Registered Number: 04075344 Charity Number: 1087939 ANNUAL REPORT OF THE DIRECTORS and TRUSTEES AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2025 AFO50BB5• #21 C(XIPANIESHCKISE RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustees Year ended 30 September 2025 CONTENTS Page Annual Report of the Directors and Trustees 1.1 Reference and Pdministrative Detaiis 12 Structu￿. Govemarte and Management 1.3 Objectives and Activitses 1.4 Public Benefft 1.5 Achievements and Perfomance 1.6 Financial Review 1.7 Plans for Future.Periods 1.8 AcknOW￿￿9eMents 1.9 Auditor 1.10 Small Company Exemption 1.11 Statement of Trustees. Responsibilities 1.12 DiSdosU￿ of Information to the Auditor Independent AudbtoVs Report Flnancial Statements 12-22 Statement of Financial Activrties 12 3.2 Balance Sheets 13 3.3 Consolidated Cashflow Statement 14 3.4 Notes to Financial Ststements 15-22 RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustees Year ended 30 September 2025 1.1 Ref•rnn¢e and Admlnlstrative D¢tsils Name: Radiology and Oncology Congresses Isometimes abbreviated to ROCI Company Registration Numl)er. 04075344. Charity NUTh￿". 1087939. Principal Offi¢•.' Fai(mc￿nt House. 230. Tad¢a$ter Road. Yo*. Y024 1 ES Registered oifKe.' FaI￿n￿nI Htyjse. 230. Tadcaster Road. yo￿. Y024 1ES Audltor. BHP LLP Rievaulx HoLtse 1 Sl Marf5 c￿rt, Yryk Y024 1AH B•nkern: Unity Trust Bank. Four Brind* Pkn. Birmingharn. B12JB Solicltors: wils￿$. A￿x￿dIa House. St Jthn's Street. Salisbury, SP1 2S8 Mtrmbern of the Conwny: The British Instilute of R**ology The College of RadK*3raphers The Instrtute of Physics and EngineeriThJ in ￿ed￿rne Radiology and Oncology Congrnss•s Board.. Board Members ar• t4)th Oirecttys of the Company and Twstees ofthe Charrty. ChaifmaTr Prof. K. Siraughan (resigned 13 March 21f251 Mr R. McGhee {Chair with effed from 13 March 2025) Chair Mr R. McGhee lunb"113 March 2025) Ms S. o'cor￿lI (appointed 10 September 21r251 Hc￿. Treasurer IAr S. 8hutla Directors Ms C. Angu$ lapFoMiled 10 September 2025) Ms G. Collinw {app￿ted 15 May 2025) Mr R.M. Evans Dr E.E. Hyde. PreS￿en1 of UKIO congress 2024 & 2025 Dr S. Islam {apK¥)irtted 4 June 2025} Prof. S.F. Keevil Mr P.W. Morgan Irestgned 15 November 2024) Prof. S.A.P.O'Connor Ms S.Purdy IreswJned 10 September 20251 Mr T.A. Welton Honorary Offi¢èrs". Marketing Support Exhibition Supwrt Finance Officer Mr Richard Evans Mrs EIEabelh eethmann MrJohn Tumer RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directo￿ and Trustees Year ended 30 September 2025 The Trustees are p￿aSed to present theirannual Trusiees. report logetherwrth the wnsolidaled fin8nual statements of the charity and rts subsKliaries for the year ended 30 September 2025 which a￿ also prepared to meet the requirements for a diie¢t(Ys' report and for Companw Ad purposes. ThÉ financial statèments o)mpty with the charl￿SAc1 2011. the CoMpan￿S Act 2Cth, the Memorandum and Articles of Associatmjn, and Accounting and Repc¥)ng by Charities." Statement of Recommende11 Practice applicable lo charities preparing their accounts in accorda1￿￿ wrth the Finanoal RewlirrfJ Star￿ard apF4icable in the UK and Republic of Ireland IFRS102) {effe¢tNe 1 January 20191. 1.2 Stru¢tsr•. Gowm¥nc• and Management 1.2.1 Governing Docum•nts The organisation is a charEtable company limrted by guarantee, incorporated on ihe 15 Seplember 2000 and registered as a ¢harty on thè 9 August 2CrfJ1. The comparry was eslablished under a MemLYandum of AssocAation which established the obSe￿S and Fowers of the charitable e¥)mpany and rt ts governed undef ils Articles of AssocAation. The current Me￿*￿and￿rn and Art￿S of Assor)atw wwe adopted al the Cornpany's AGM held on September W 2020. 1.2.2 R•crullm•nt #nd Appdntsmnt of Boa General meets"ng5 oflhe {￿mpanY are erther the Annual General Meetin9 IAGM) ¢y an Exlraordinary General Meeting {EGMI. The Directors of Ihe ¢orN)any are also Trustees of thè charrty. Each of the Members may appoint up to Iwo Directors. Three Honorary Officers. beir¥J the Chair. Vrce-chair and TreaSu￿r are ek¢ted by the members at either the AGM or an EGM for three year terms. and Presthnt ofthe Congress trom ts.me 10 time 1$ elected by the other Oirectors. 1.2.3 Tn￿tre Indu¢tlon and Tralnlng All Tfustees are familiar wilh the wort of the charity and most have served as Trustees of the member organisattiins or ￿lated orgarttsations. The Trustees are rnade aware of theif obl•3ab"ons. ￿ dire(#ed lo the Charity Commission website for fvrthef guHlance and a ROC Handbcok is wowded. The Board reguigrfy reviews t*thelher any further Irarning 15 required. The Board continues to moThtor the mix of skn'lls wov#led by the Trustees aThl attempts to en5we the Board has a spread of apwopriate sknlls. 1.2.4 Risk Management The Board regularfy reviews the iisks to wh￿h the charity is ex[￿ed aThJ listed behx are the srA highest identffied risks, together with the steps being iaken lo mitigale those risks. Relationship wiih. and ¢ommitment of. professional bodies Involved In radiology and on¢ology- SCOR. 81R. IPEM. specialist societies etr. - promoting multi*rofessional rneetings. All Board members are aware of the importance of commitment and goc¥J working reLationships be￿een ROC. rnember organisalions and other part￿5. and strive lo maintsin them. Where ¢onfli¢ts of inlerest exisl Ihey are dea with Iran5parentty. A high emphasi5 15 placed on workn.ng in partne15hip. ie¢ognisiAg the ¢onth"bulions and perspectives of all concemed. Promotion of multi-dt5ciplin•ry Con9rES￿ ¥nd risk of c¢xnpeting events Imutli4is¢iplinary in UK and abroad + specialist society meetings) The prornotion ol mulli-disaplinary Congresses is one of a number of fvndamenlal Joint Objectives agreed by all ROC'S member organisations. Board Mem￿r$ are awarè of thè nèed to bè aware of potentially competing events which rnighl adversety impad on delegalelexhibrtor numbers and keep such matters under Strateg￿ review. RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustse$ Year ended 30 September 2025 Appropriateng$s and a¢cuTrcy of ¢ontent ofCongm$ prngramm•8 All aspecls ol Congress programmes are wewetj. pr05peclNely and ￿trOsPeCt￿ety. al regulaf Board meetings. Congress Presidenls play a partiujlarfy important rolÈ in Ihe development of the ¢J)ntenl of Congress pr(yJrammes, with oversight by the Board. Continued attracliveness and relevance of ROC events cong￿$$ Presidents, who are appointed by the Board. are experts in their fields. They are 5UPPOrted by multidisciplinary colleagues wth. a good understanding of the Continuing Profèssional Developmenl needs of delegates. All cy)ncemed are stror•Jty molivated to ensLrt the L)Jntinued attractNenèss and relevance of ROC evenls. in line with ROC'S thantable object. Complets tailuYelcanc•llat•on of an event Preparations for events. including asswaled fina￿la1 risks. a￿ kepl under o)ntinual rewvw. al￿)Ment¢d by minuled reports at ROC.E board meetings al inlervaLs. We have ¢Mtraded a professional Conference organiser, W￿lse day-to-day business is to ensure the success of events. The charrty ￿ further protected by an insurance policy against sudden ￿n￿lIa1￿)n oflhe e¥ent for oulsKle ar¢umstances other than a pandemic. 1.2.S Organisational StrucbJr• The Boaid meets at least h¥ice a year and the pn.mary ￿ponSIb￿rt￿ ofthe Board, the three Honorary OffKers and the Execubve Commrttee are set out in the Articles ol Association. Board effei*iveness is wewe(l as part of an ￿- goiig process ol rewew of all ROC and ROC-E operations. The charity does not employ any managenwit staff. Strategy deoson$ are dtscussed and approved by Ihe Board of Trustees. and operational delivery is the respon$ibilty of ROC Events Ltd. the WhdIy-￿lned $ub$idiary company, reporting to the Board of Trustees. The Board is supported by a qualffied Finance Officer who provides financial and administrative support. who receives a rnode* payment. and the services of a ProfeSsK￿al Conference Organi5ing company. Company Secretsiral responsibilities a￿ undertaken by one of the mernbefs. IPEM. for wh￿h it is remunerated. None of the Board members is femunerated. There are tsvo Committees repo￿"n9 to the Board. The UKIO Orrjanising Comrnitteè- all members oflhe committee are volunteers. This ¢ommrttee ath.ses Ihe Board as lo the siaentfft programme for the annual UK Imaging and Oncology Congress. Thefe is also a Finance Cofflmitlee Chai￿ by Treasufer which the FinancA Officer and a representative oflhe ProfesS￿nal c1)nfere￿ Or9ani$er attend. 1.3 Obl•ctiv•s and A¢ti¥itl•s The object of the Charity shall be to advance educati￿ in radiology. oncol)gy and related scie1￿e$, particul8dy by the prO￿$10n of congresses pertainin9 to the radiation soencès as applied lo medicine. and the disseminatM)n fof pU￿1C benefrt of the usefijl resutts of repwts of research arisng from such f))rvJr•sses. The company brings togèther ofthe main UK profess￿1 oryanisations invofvèd in radKAogy, med￿1 imaging and radiation oncokjgy lo organise an annual mapr combined event encoffyas*ng diagn051ic and theiapeutic use of imaging and Tadiat#Jn. The main objeclive lor 2024- 2025 was to organise the UK lrnagng arKI On¢ology Congress {UKIO). The 2023 and 2024 congresses had teen very wdl attended and Ihe Tmslees were cautiousty optimistic that the 2025 event would prove lo be Èqualty successful. Vobjnteers undertake most of the ￿ganising of ihe sc*ntthc planning ol the ￿)ngresSeS. RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustee$ Year ended 30 September 2025 1.4 Public 8eMfft The Trustees have complied ¥￿th their duty in Secti￿ 17 olthe Chwrties Act 2011 to have due regard to Ihe guidance on publi¢ benefft published by IhÈ Commissth in exercising th￿1 Fvwers and planning the activities of the chaTIty, ir￿lUding the guidance'Pubh"c Benefit.. running a charity {P82)'. The company has charrtable purposes. a$ set oul in 1.3 above, which are fw publbc benefft. They Cover thr88 of the e$¢riptions of charitable purpose Set oul in the Chaiiti"e$ Ad 2011.. The advan￿ment of education: The advancement of heallh". The adVar￿EMent ofthe arts, c￿nUTe, heritsge tx swi¢e. The Charity Commi55K>n has set out two key of Publ￿ benefft: There musl b• an identifiable benefft or ben•ffts The congress. whr¢h the Chanty organises as rts main acimty, advances the ed￿￿.0￿ and training of a range of persons invofved in heath¢are through ￿Ures. debates and teaching sessions that not onty relate lo clinical pract￿& tr¥Jt also include service delivery and standards. 11 also adVan￿S sC￿ntif￿ knortledge in medicine anil related areas. These hvo types of activities promote the advancement of educa1￿. heahh and sctence. Benefits m￿t be to lh• publlc. or s•ction of the public The main direct tenefiryaries of the a¢Jiwt*s of the chanty are heatthcare professionals and resèarchers involved in the areas of medical imaging and treatment of cancer usiThJ radiatKJn. The main professions involved include me¢j￿1 dcttors, radiog¥aphers. medKal physiosts and induslrialisls. Undedw'ng the enbre operations of Radio109y ant1 On¢olo9y Congresses is the b￿￿f thal rts acbvrt*s are to thè bènefrt ol the publK. and in particukr to patients urKlergoirtg diagnoslrc or therapeut￿ lad￿k)gIcal prwedures. The congress is open to *1. v*ilh no preferenlial regi$tratwJn fees for of particukr S(￿11e$ or organi$ations. There are wide public benefits from improved heatthcare resuliing from the actMtie5 of the ¢harrty. In 2023 ROC ueated a bursary SCheff￿ lo enable a numbef of practit￿er$ from countries on the United Nations h.sl of least develoFed coL￿tr￿S (UNCTAD) to attend_ In 2025 we exterM1ed the list of countries to include other le55er develoF*d rountries. Thus. we wdcomed 8 attendees frryn Nepal. The Gambia. U9anda, Ethiopia, Ghana and The Philippines. These grants ¥e in addilion lo academic grants to a fvrther S indpiidu*s frcffl Ghana. NMJeria. Kenya and Nepal 2025 saw the second year of Ihe'Pilch your Proje¢* competrion. Six submissK#is were sI￿)rt11$1ed for a live wtthing session al the Congress wh￿h resulted in 4 projects being each granted £5.th)O fvni1ing. Thewinners submit periodic progress ￿aleS and will present the résulis of th*'r resea(ch at the 2026 Congre35. Radiology and 0￿￿09Y Congresses doe5 not engage ￿ any rn)liti"cal aclivity. 1.5 Achievements and Perforniance Radiology and Oncology Congresses (ROC} is a charitable cornpany. registered wrth both the Charty Commission and Compan￿5 House. It is a pnvate limrted company incorForaled by guaTantee. Its aims and activrties are encapsulated in its charitable objecl- lo a￿Va￿e educatton in rath"ology. orLology and related sciences partiGularfy by the PffOws￿rt of congresses pertaining to the radialton sCie￿e5 as lo medAcine and the dissemination for the public benefit of the useful ￿5($￿5 olrew)rts of rssear¢h ari&ng from such Cong￿sses. The cong¥ess look place al the ACC in Liverpool June 2f*Y4h wrth the Iheme'community and C¢)n$aousness'. One Health RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustees Year ended 30 September 2025 The number of indivKJuals regislered ftjr atten¢Sn9 was 3.140. 35% h￿her than Ihe 2.330 ￿giSte￿ in 2024. The number of sessions on the nuin programme was 116, delivered by 237 speakers and Ihere were 99 education on the stand sessions. 2025 Saw the third year of the "reseaT¢h hub. where researd)Èrs could recruit parti¢ipants from UKIO'S muKbprofes5ional attendance. The Patbent centred 5e&sions were exlremely successlul and well attendetj. The feethjack on the 2025 ￿ngresS wa5 posibve - %% of dewtes rated Ihe venue a5 ex¢￿Ient or gN)d', 92% thoughl it was aboui the rqht length and the excdlent or gc*)d ratings for the pre-congress and onsite managernent We￿ 92% and 95QA respe¢livety - all these scores are bro&JJy the same as for 2024. The catering arrangements were less well received by delegates trAJt nevertheless Showed an improvement ow 2024. AJI feed*k 1$ being assessed wrth a wew lo improwng the delegate and exhibitor eXp￿n¢t ne￿ year. The Diwlor$ have for some time recognised that finanoal aThJ workkjad pressures affeci budgets and abilily to atterKI edu¢ab"onal events aryl been awafe of the opportunrt*s ant1 challeThJes of aspects such as dMJitisats"on of education81 provisitin. It is apparent is that there is sth"Il a 5tr0ny dèmand for eompTehensivÈ "broad brush. flagship events such as UKIO and the netsvorkng opportunth.es it offers and the 2025 meeting will orKe again lake place in Liv8rpool in June 2026. 1.6 Fin•n¢ial Review 1.6.1 Financial Actlvltitis Total in¢ome for the year lof the charity was £113,271 12024.. £169,978). Charita￿e expenditure incurred directly by Ihe Group totalled £43.339 (2024." £27.598). Direct operat￿nal and governance costs totalled £31,794 (2024.. £54.8941. The Group figures f¢y 2025 refiect the IndUsw￿ of the gross ifKome and expendrture for the thOri￿s trading subsh1iary, ROC Events Ltd. whth runs the Unrted Kingdom Imaging and Oncology Congress IUKIOI on behalf of the charity. The Congress's generated a profft of £94.220 12024.. profrt of £89.501). The sury)lus h3$ enabled the Charity to ojver its charitable spen(ling and dire¢a OkwatKJnal and go¥eman¢% costs and conlribule to an increase in Reserves of £43K. wrth 5ustsined surpluses. the charity has been able to ¢ontnue to make grants. The programme of bursaries to atter￿eeS from Lesser Developed and midd￿ Incfjme Countries wrth 8 attèndance and S acadèmic bursaries patd in 2025. Under the banner-Pitch your Proied" four 9rnn15 of £5.WO eath We￿ awarded for ￿Search, autjit or seryice improvement projects. The Charity a150 funded the cost of pubthshing the 2025 ￿ngresS papers. Work is on-going lo identify further areas Whe￿ the charity might tetter use its saentific meetings to engage with the broader public and encourage Ihe developmenl of young profesSion￿S wthin the sector. 1.6.2 RÈs•Th The group surplus of £42.857 has caused the group reserves. which are equal to the free reserves. lo inuease lo £686.033 as at 30 September 2025 {2024." £643.1761. The Trustees have rewewed the Reserves Policy and believe it appropiiale lo hold reserves of al ￿ast £450.0(xJ to proyKle working caprtal for the Group. as suitable vènuès need to be booked significantly in advance to ensure stability for the events organised by the charity. The long-term objeclive of the Trustees is for thè Congress to cover tts own (x)sts and the operating expènses of the charity and use any surplusfor bufsarie5 and grants. The Trusiees will review the Sliategic requirernents of the scientific meetings in Ihe coming years to build on the current outreach elements of Ihe meetings and consider that the balance of free reserves whth w111 $b"Il be available prwdes a ffimi financial base for thiebpmenls. RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustses Year ended 30 September 2025 1.7 Plans for Future Perlods The Success of the 2025 event demonstrates the continued ap￿rte from delegates and exhibttors for a physical congress- pmided of course that be held safely. The 2026 event will relum lo Lr¥erpc#)l in June next year. 1.1"Acknowl•dgements The Board of Truslees wishes lo pay tribute lo Ihe enom)ous hard WO￿ by the congress's President and Organising Committee. on whom the success of the congresse5 is entirety ¢Jependent. The Board also wishes to acknowledge the excellent con1n1￿tion of the WofeSs￿al ojnlerence ￿j￿Iser, Profi* ProdU¢b"0￿ Ltd. toward$ Ihe effective and professional Sta￿n9 ofthe 2025 event. 1.9 Auditor Following a competitive tendef process. BHP LLP was appointed fc( the audit or the 2025 finanrial statements in $uttession to Smfth & WIliams￿ Iformerty known a$ CLA Evetyn Partners) who had held the role since the period ending September 30th 2019. Sumer Audrtco Limited were appointed as audrtor to the company folkiwing BHP LLP becoming part of the Sumer Group on 31 December 2025. whth required a thanye in audrt firm lo comply wtth app1¢Cab￿ regulalory requirements. In accordance with seCt￿n 48712) of the Companies Act 2006. Sumer Au¢Jitco Limited are deemed to be reappointed annu*ty. 1.10 Sm•ll Company ExÈnWIooi The report and the finawal sta*ments ha￿ been yepored in xoydance the ￿Ls1On5 ofthe Companyès Act 2CQ6 ￿lating lo small companies. 1.11 ststoment of Trustees. Responsibilities The Tnjstees (who are a150 dire¢iors of the Radiology and Oncofogy Congresses for the purposes of ¢ompany law) are responsible for prepanng the Tru$lees' Report and the financaal statements in 8ccordan¢e wrth applt¢able law and United Kingdom Accounting Standards {Un*ed ￿ngdorn Gerwally Ac£epled ACr￿jntlng PraLlicel. Company law requires Trustees to prepare financaal slalernent5 for ea¢h finan¢kal yearwhth give a true and fair v oflhe slate oflhe affahrs ofthe charitable company and the group and ofthe in¢off* and expenditure ol the charitable group for that period. In prÈparing these finanaal statements, the Trustees a￿ required lo- select suitable a￿ountry poI￿leS and then apFty them consislentty: obserye the methods and prin¢ples in thg chariti￿ SORP; make judgem¥nts and eslimates that are rea%￿able and prudent: stale whether applicable UK Accounling Standard5 have been fOll￿ad. subpd to any materBI departures disclosed and explained in the finanaal staternents., prepare the finanaal statements on the going wKem basis urless rt is inappropriate lo presume that the Charilable ¢ompany ￿11 continue in business The Truslees are responsible for keeping prtsper a¢cAiuntin9 records that discbse with reasonable actyJra¢y at any "me the finanaal poSit￿n of the charitable company and enable them lo ensurè that the financial 5talernents compty Ih the Gompan*s A¢1 20c￿. They are also responsible for safeguarding Ihe assets olthe charrtable wmpany and Ihe group and her￿ lor iaking reasonalle step5 for the prevention and delectKsn ol fraud and other irregularities. RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustees Year ended 30 September 2025 1.12 Dl¥clogurn ol Infomialion to the Auditor In so far as each of the tnjstees are aware.. Ihere is no fe￿vant information ofwlith the charita￿e ¢fAmpany's auditor un•Hafe'. and Ihe Trvstee5 have taken all relevant slep5 they ought lo have taken lo make 1hem5el¥e5 aware of any relevani audit inf(¥mknn and to establtsh that the tharitable com￿Y'S audrtor is a4¥are ofthat inlomialion. b} Si9ned on behaw ofthe Trustees ty. Ireclor R. McGhee 25 Mar¢h 2026 RADIOLOGY AND ONCOLOGY CONGRESSES IIIDEPENDENT AUtMTOR'S REPORT TO THE MEMBERS OF RADIOLOGY ANO ONCOLOGY C014GRESSES Opinion We have audited the financial 51atemen15 of Radiology and Oncdogy Congresses Ithe'parent charitable compan*) and its subsidiary {the'group'l for the year ended 30 Sepiember 2025 Wh￿ comprise Consolidated and Company Statement of Finanaal Activrties. the Group and Cornpany Balance Sheets, the Con501idated Cash Flow Stslement and the note5 to the finanual stalemenls. including signfftant accounting policies. The financBI reportin9 framework that has been applied in their preparaknon B appl￿b￿ law and Unrted Kingdom Accounting Standards, including FRS 102'The Financial Reportmig Standard appI￿￿e in the UK and Republ¢of Ireknd" (Uniled Kingdom Generally A￿epted Accounting Pra¢*"¢el. In our opinion. Ihe ffinanoal smements.. give a and fair of the stste of the group's and of the parent charitable company's affairs as at 30 Septsmber 2025 and ofthe group's income an¢J eXpen¢jitu￿ for Ihg yèar then ended., have ￿en propety prepared in accordance with United Kr￿d0M Generalty Ac£epled A¢￿unting Practice.. and have bw p￿Pared in accordarKe wilh the ￿Ul[ements oflhg Companigs Ad 2(M)6. 8a$is fot opinion We conducted our audit in X¢OTdarKe wrth Intern**)nal Standards on A￿d￿ng (UK) IISAS (UK)) and applicable law. Our responsibilities vnder Ihose 51andards are further dewbed wi the Audilorfs respJnsibi1it*5 for Ihe audit of the financial statements sectKJn of our report. We are independent of the group and parent charitable company in a¢¢ordan¢& with the ethical requirements that are relevant lo our audrt of the financial statements in the UK, including the FRC'S Elhul Standard. and we ha¥e fulfilled our other elhral res[￿sIbI1rtles in accordance with these requirements. We bel￿ thèl the aLbJrt eM*nc4 we ha¥e obtained is Suff￿￿1 appropiiate to prowde a bows our opin￿n. Coneluslons rnlating to going concern In audrting thefjnancial statements, we have ￿nduded thatthetrustees. useofV)è goiThJ concern basis of accounting in the preparatKtrn of the finanaal statements is appmpri*e. Based on the work we have perfomed. we have not wjentffjied any material uncertaint*s ￿lating lo evÈnts or condrtions Ihat. individualty or collectP4ety. m8y cast signffi¢ant doubt on the group and parent charIlab￿ company's abilty lo continue as a going corKem for a period of 8t least twelve mfmths from when the financial statements are authorised for issue. Our responsibilities 8nd the o$p￿sibIlI1•S of thetrLtsteest*rith reSp￿tIO going cortem are dets￿bed in the ￿levant sections of this report. Othw infomiation The other information compn.ses the infomation included in the AnrtU81 of Ihè Dirnctors and Trnstees and FinanciJl Ststen*nts. othÈr than the financial statements and our audilorfs report Ihereon. The Iruslees afe sponsible for the othef informatK)n contsined within Ihe Annual rgport olthe Dirnclors and Twst&es and Fin8nc¥al Slatements. Our opinion on the finarrial staterrents dces nol cover ¢he other in1￿M?ti￿ and. except lo the 8Xtenl olherwise expliriuy staled in our repx¥l. we do not express any fcrn of assurance l￿du￿)n Ihefeon. Our responsibility is to read theother informatK)n and. li dtyng $0, considerwhether Ihe other informat•Jn is materially in￿nsIstenI with Ihe financial siatemenls of our knOw￿dge obtained in the coutse of the audrt or otherwise appears lo be rnaterially misstated. If we it1entfy SLth material inconsisten￿eS or apparent material rnisstalemen15. we are required to delermine whelher this gNes rise lo a rnalerial misststemenl in the finanoal staternents themselve5. If, based on the work wè have perfomed. we condude that there ￿ a material rnisststèmènt of this other inlormalion. we are requirèd to rewrt that fact We have nothing to report in this regard. RADIOLOGY AND ONCOLOGY CONGRESSES Oplnlons oth othèr mattern prescrlbed by the Compan•es Act 2006 In our opinion. based on the work undertaken in the course of the audit.. the information given ￿ the Trustee5' Annual Repjrt. which indudes the Di￿(#0rs, Raport prepared foc the pvrposes ofcompany law, for the finanrial year for which the finanoal statements are prepared is con5islgnl with Ihe ffinanoal Statements; and the DirectOTS' Report ￿Cluded wrthin Ihe Trustees, Annual Rewl has been yepared in a¢xordancg Wbth apph'cable legal requirements. M•ttern on wlbich we •rn r¢quired to report by •xeeption In the loht ofthe knOw￿￿ge and understanding of the group and the pa￿nt¢harIIab1ecompanY an¢Y Iheirenvironmenl oblained in the course of the audit. we have ￿t klenlif*d material misststemenls in the Directors, Report included within the Trustees. Annual ReF¥yt We have nothing to report in ￿pect of the folkmfing matters Mi rfatitin to which the Cc*npaniès Act 2006 ￿quIreS us to report to you rf. in our opinion.. adequate ar•>)unts"ng retr)rd$ have Mt been kept by thè parent tharrtable ￿mpanY. or return$ adequate for our audit have not t*en receNed fr￿￿ branches ￿ ￿srted by us,. or the parent charrtable company finar￿￿1 Stat￿nts are nol in a9reement with the accounling records and retums., or certain dis¢Jtssures oflrustees. spwffftl by law are nol m*., or we have not recwved all Ihe infom*bon aThJ expknalion$ we require for our audit., c the trustees were not enlrtkd to take &Jvanlage ofthe small ￿mpar￿e5, exemplM)n from the requirement lo prepare a Strateg￿ report. R•sponsibiliti•s ol trust•es As èxplained more ful￿f in the Statement of Tnjstees. RespOn￿bilr(les set out on page 7. the trustees (who are difectors of the parent charrtab* company for the purposes of company lawl are responsibk for the preparat¢on ol the finawal slatements and for being 5altsfied thal they 9i¥e a true and lair vivw. and for such intemal control as the trustee5 determine is necessary to enable the of finanoal statements that are free from matsrial misstatement, whether due to fraud or error. In preparing the finar¥ial slatements. the tfustees ¥e reSpOrtsib￿ for assessing the group and parent charitable company's abilty lo continue as a 90in9 concem, di8ctr)siThJ, as applKablg. matters related to going concem and using the 90ing concem ba$1$ of arxounb.ng un￿S the trustees either intentj to liquidate the group or the parent tharitable ¢ompany or lo ￿ase operations. ty have no realtsl¢ altematr¥* but lo do so. Auditorfs responsibilities for the audit of the financial stslem•nls Our rtjjectives arg lo oblain reasonab￿ assurance aboui whether the finanoal statements as a whokn are free from material misstslemeftt. whether due lo fraud or error. and to issue an audrtorfs report ihat includes our opinion. Reason8ble assuran¢* 1$ 8 hrgh ￿Ve1 of assurance. bul Is riot a guarantee thal an aLMlil condu¢ted in acct)rdance with ISAS IUKI wll aNYays detect a rnalerial rnisstatement when rt exists. Misstatements can arise from fraud or error and afe considered material rf, indmdually or in Ihe aggregate, they uxjld ￿asOnablY be expected to influence the e¢onomi¢ detssions of users taken on the basis of these finanoal slatements. Irregularilies, induding fraud, a￿ instances of non-¢offlplIan￿ with laws and regublions. We design procedures in lirtÈ with our ￿SPOnSibl1￿1es, oullined above. to detect material misstatements in ￿SPect of irregularities, including fra￿J. The extent lo wh￿h our procedu￿5 are capable of ¢Jelecting irreguLants"es. including fraud, is ¢Jetailed bek)w'. Our appioach to K1entfying and aSseS￿ng the risks of material missialement in respect of IrreguL4rit￿$. induding Iraud and n￿-￿mplIanCe with law5 and regulatw)ns, wa5 as follows". the engagement parlner ensured that the engagement team collectNely had the appropriate competence. capabilities and skills to idenify or recognise non-cornplian¢e with aP￿tsbIe laws and regulations." we identified the laws and regulations applicable lo the group and company through discussions with dire¢tors and olhef managemenl. and from our commercial knowkedge and experiènce of the sector." we focused on Specif￿ laws and regulations which we ¢>)n5idered may have a direcl malerial effect on the 10 RADIOLOGY AND ONCOLOGY CONGRESSES financial ststemenls or Ihe Operat￿nS of the company. incluth.ng the Companw Act 2￿6. tsxation legislation. dats prole¢tK)n. environmental and hearth and safety legisLilion.' we assessed the exlenl ofcompliance with the laws aThJ wulation$ identffied aty)ve thr(￿h making enquiries of management and inspecting legal cx)rre5pondence." and idenl1r￿d laws and regulat￿nS were c1mmun￿led wthin the audit tearn regularly arKI the team refflained alert to instances of r￿*•CoMPlian￿ throWcMJl the aLwJrL We a55essed the susL*pl1b￿ty of CoMpan￿S financHI slatements to material misststement. induding obtaining an understanding of how fraud might o¢xvr. by". mak.tng enquiries of managernent as to where they (y)n5idered trEre wa5 SU51xptitility to fraud, th8ir knoW￿dge of xtual. SUSFEde￿ days Inveslmenls in deFm)srts>￿ days 19.105 75.000 185,463) 17,845 {236.5751 Change in cash and equ￿lents ￿ the le[￿1r￿j perk)d 30.278 {240.4531 Cash and cash equivalents at the beginning of th& rgpthn9 period 370.412 610,865 Cash and cash equivalents al the end of the reptyt.ng penod 400 690 370.412 Note 1 Reconcillation of net •xpenditurn to n•t ¢*sh flow from 0￿￿ting acbvil*s As restsled 2D24 2025 Net income for the repoth"n9 period DÈcrÈasèl{Inuease) in debtors Decrease in creditors Intefesl receivable Nel cash provided ty l {used inl operakng aLaNrtie5 42.857 30,561 19,979) (24.4601 17.845 21.723 13,0981 Note 2 Analysis of cash and cash •quivalenl¥ Cash in hand Tol31 cash and cash equNalents 400.690 400.690 370,412 370,412 Priorye•r restatèmÈnt of the ¢¥shfl¢)w Interest receivthe has been wlassified from cash fl¢Ms wovided by operating acti￿lIeS lo cash flows from investing activities. The prior year ffigures have been restated lo rellect thi5 change. This redassification does nol impa¢t any othef areas of the finanoal statefflents. 14 RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Ststernents For the Year Ended 30 September 2025 (Continued) A¢¢ounting Policies Company information R3￿￿ogY and On¢obgy Congresses is a company linited by guarantee domiokd and incorporated in EnglaThJ and Wales. The registered office is Fairmounl House. 230. Tadcaster Road. Yth Y024 1ES. b) AC￿￿ntIng Conventb The financial stslemenls have been wepared in accordance ¥Mh Accounting and Reporting by Charities.. Stalemenl of Recornmended PraclKe applicaUe to charibes preparing their accounts in a¢Cordan￿ wilh the Financial Reporting S￿ndard applrAble in the UK and Republic of Ireland (FRS 1021 leffertive 1 January 201951 ("Chant￿S SORP (FRS 102).). the Financial ReF¥xling Standard applicable in the UK and Republi¢ of Ireland IFRS 1021 and the Chanb"e5 Act 2011. Radidow and On¢ol¢)gy CorvJre$se$, and the group whith it h8ads. meets the definrt*)n of a public bener ents.ty under FRS 102. The financial slaieffthts have been prepared on the historical ojsl Convent￿n. The prinopal a¢￿untIng )lioes adopled are set oul bekx. The chantabte cornpany has tsken a¢fvantsge of the exerythb.on allowed undef SeCt￿rt 408 of the Companies Act 2006 and has not presented its (Ywn s￿lement offfinanc4al activrt*s in these finanual stslements. The finarri* sl*ements are wesented Ai sterling. Goiro Concem The Group ran a full congress June 2nd4th 2025 in LNerFwI. As detailed herein, the result for the year ending Septembef 3(￿ 2025 was a surplus 01 £42k wh￿h has InC￿aSed the Group reserves to £686k. Looking ahead and building on the success of the 2025 cong￿5$ we ￿11 run the 2026 event, in the same venue and in the same format. We have commrtled to njn the 2027 and 2028 events al the bwnue also in subslanlially tho same formal, subiecl lo impfovernents refiectng parb"opanl feedback. In t￿ light of the success and financaal profftabilty of the 2025 coThJress and the plans for the 2026 0)ngress. the Direct￿$ are of Ihe opinK)n that thère is reasonable assurance thal the Group will be able to continue as a going concem foral leastthe tsvejve monlhs folb)wing the approval ofthese a￿lunts. Accordingly, Ihe ffinancial sktements have been drawn up on the goirwJ ¢on¢em bay"$. d} Consolwjati Rad*Sogy and Oncobgy Conyresses tr￿fi$ the whde of the shafe ca￿.141 of ROC Evenl$ Ltd. The Dir8Ctors have elected Io Prepare ojnsolidated accounts and the group financial statements cons0￿"date the ffinancial stslements ol the company and ROC Events Ltd. The whole of any profit of ROC Evenls Limiled, which would otherwise be subject lo ¢orporab"on lax. is donaled to Rad￿l0￿Y and Oncok)gy Congfesses. Income Activibss in fUrt￿rar￿a ofthe chariVs ofyedN8S Inryjme is re¢L>Jnised when the charty has enlrtlemenl to the fvn¢J$. any k)thmiance ￿ndrtIonS attached lo Ihe incorne have been fflet, rt is probable that the income will be received the amount can be rneasured reliably. Events income is a¢¢ounted for in the per￿ in whth the event lakes place. Investment income Investment income is accwnl for on an 3￿r￿ats ba515. 15 RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Statements For the Year Ended 30 September 2025 (Continued} Fund accounling General funds a￿ available for use at the disuetion ol the Director5 in furtherance of the objeclNe5 of the charty. Taxation The Charity is considered to pass ihe tests set oui in Paragraph 1 Schedule 6 of the Finance Act 2010 and Ihefefore rt meets the defjnition of a charitable company for UK ¢orN)ration tax putr*)ses. Accordingly, the Charity is potentialty exemm from taxat￿￿ in re5pecl of intome or caprtal gains received within categories covered by Chapter 3 Part 11 of the Corporat*)n Tax Act 2010 ￿ Secaion 256 of the Taxation of Chargeable Gains A¢t 1992. to extent that $u¢h incAxne or gain$ are applied eXdUSNe￿ to charitablè purposes. h) Inveslments Investments in suosbjiariès a￿ valued * cost less proNis*Jn ftr impalm￿nt. Debtor5 Trade and ¢)ther debtors are recognised al the selllement amount after any trade discount offered. Prepayments are valued at the amount p￿paid net of any Irdde discount due. gl Expenditu All expenses afe accounted for on an ￿￿ualS basis. Bursary costs are rethJnised at Ihe point they a granted asstsming th8y are uncondi1￿nal aThJ speciffic to the ndividual Expenditure incurred in connection wryth the Specific obj.ecls of the charity ss indLwJed under the heading Charitab￿ expenditure. £Xpendrtu￿ is dassrf*d by thè category of acbwty which rt is used rathar th•) by af expense. k)calion i% on an adual bass. or where this is not poss*)le. on an esb"maleil usage basis. Charitsble *Nilies eyndiiwe ir￿￿de both Ihe direct costs and supwt costs relating to those acti￿1*$. Govemance costs irdude those in¢ufrei1 in the goveman¢e and strateg￿ management ¢)f the organi5ation indudin9 Costs asswated vthh meeting ¢onstrtu¢tonal and statulw requirements. Support costs, including Go¥emance costs, are alkncaled Io c051 categories based on dire¢t costs in those categorRs. h) Liabilitie5 provisions Liabilities are recognised as SOM as ihere is a wl or ctr5tructhve ¢)bJigation ¢ommrtting the Charity to the expendrture. Cash and Cash equNaJents Cash and cash equivalerts indude cash in ha￿1 arKI at bank. arnl deposts held at ¢all with bartks. Financial Instruments Tl* Group has eleded to appty the pmvsKJns of Secttyjn 11 'Basit Finanaal Instruments, and Seclion 12 'Olher Finan¢Fal lrtstruments Issues, of FRS 102 to all of its financial instruments. Financial instruments are recc*Jnised in the group s ststement of fmanoal F<)Srtion when the u)mpany be￿MeS party lo the contractua wovtsions of the inslrument. Basic financr41 assets, which ￿￿L￿le trade ar*J other debt(￿$ and cash and bank balances. are initialty measured al Iransacbon piKe induding transaction costs and are subsequently carried at amortised ￿5t using the effecbve inlerÈst method unless the afrangement ttjrnstrtutes a financing transacknon. where the transaction is measured at the present value of Ihe fthure receipts dis¢tsuntet1 at a markel rate of interesl. Ba5icfinan¢ial liabil(ties. includww trade ar￿ other creditors. are inrtially fe(x)gnised al Iransaction price unlèss the arrangernènt conslitutes a financing iransaction, where Ihe debt Instrument is measured al ihe presenl value of the future payments discounted at a mathel rale of interest. 16 RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Ststements For the Year Ended 30 Septsmber 2025 (Conllnued) Debt wislruments are sub5equentty carlied at amortj.sed co$1. ugng the effective interest rate methc*l. Trade creditors are obl*Jali￿$ to pay gc￿$ or seNces ihat have been acquire(l in the ordinary ¢ourse ol business from suppliers A¢¢ounts Payab￿ are daS￿fied as ￿rrent l￿bIlitIeS rf payrnenl is due within one year or less. If not. they are presented a5 wl-¢AJr￿nt liabilitiÈs_ Trade cred¥tors ale recognised initially at traTrsact￿n pr￿ and subseqLrentty measured at amorti8ed cLJst Using the effeoawe interest method. k) Prior year redassffication The charity reviewed Ihe presenlation ol ￿rtain deposrt alxounts lolalling £236.575 as at 30 September 2024 previousfy classified within Cash ai Bank and in Hand. These balances related to notice deposrt5 with malurity dates that. in a￿(Y￿an0 wrth the requiremenls of FRS 102 and the charit￿ SORP, are more approprialety presented as Fixed Asset Investments. The Tru5tee5 have taken Ihe de0$￿ to redassrfy these balancks to provkle a more true and fair rep￿sentat￿n of the nature and IiquKIty of Ihese funds and lo ensure cons1Stenw 7fvnth charty's accounting polioes ￿ irNesifflents. There has been irnpacl on the tharty's iewrted resulls for ether the ￿rrent or comparatrve year. and net assels remain un(*anged due to thi5 rec1assts1￿n. Critical Accounting E3tlmat¢s afftd Judgem•nts In the application of the Charity's accounting F¥)l•ies. the Trustees are Tequired to make Nidgemenls, esbmates and assijmplions aboul ￿ carrying amount of assets and liabiliti'es Ihal are not readily apparent from other sources. The esb"mates and assoriated assum0K￿$ are ba$ed on hisiorical eXperIe￿e and other factors that are co￿￿1ere￿ to be re￿Vant. Actual resulls may diffef from these estimates. The estimates and undertY￿g assumptions are reviewed on an ongoirKJ basis. Rewsrth)$ 10 8ccounling estimates are recognised in the period in which the estimale is revised, rflhe revision affects only ihat period, or In the period of the and ftrture pefiods rf the fevision affects both ojrrent and fvtU￿ periods. Thwe are no estimates and assumplK)ns that have a Synif￿￿t risk of causin9 a material adjustmeni to the rrying amount of assets and liakn"liti"es. Member5. Guarnntee Radiology and Onthlogy Con9rèsses ts a ¢*rrpny limiled by w￿antee in England and Wales and has a IKence to dispose of the word "limrte11- in rts trtbe. The members a￿.. The Britsh Inststule of Radiobgy, The College of Radiographers. and the Instrtule of Physic5 and Engineering n Mediryne. In the event of a winding up. the Ikabilty of ihe thre8 members would n(rt exceed £1 each. 17 RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Statements For the Year Ended 30 September 2025 (Continued) Analysis of Charitable Expend5ture 2025 Dire¢t 1.560 8.126 Admln Govemance Totsl 1.560 8,126 20,000 Publishing rAJfrent yea¢s confernnce papers Academic Bursaries Research Grants Bursarie5 for attendees from lesser devebped countries UKIO 2025 confe￿nCe (note S) 13.653 816,049 859,388 13.6S3 863.13$ 906.474 34.205 34.205 2024 Dire 1.620 Go¥emance Total PU￿1$hing prior yearf$ ty)nf¥e￿ papers Academic Bursaries Research Grants Bursaries for attendees from18sser developed countries UKIO 2024 conference (note 5) 20.CMJ) 20,OCQ 5.978 774.474 802,072 5,978 861.377 888 975 47.212 39,691 The Group employed no staff in the year12024'. no￿}. Anatysis of Ch•rftable EXp￿difu￿ Coryiany 2025 Dirn¢t Admln Governance Total 1.560 8,126 20.01)0 Publishing current yearfs conference papers A¢ademi¢ Bufsaries Research Grants Bursaries for attendees from lesser de¥eloped countriès Support Costs 8.126 20,OOD 13.653 13,653 31,794 7S.133 12.881 Company 2024 Adm Govemar Totsl 1,620 p￿blishIng cur￿n1 yearf$ conference paFers Academic Bursaries Research Grants Bursaries for attendees from lesser develoF*d countries Support ¢o$ts 20,IJ)O 5.978 5,978 54,894 82.492 39.691 39,691 15,203 15.203 27,598 18 RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Statements For the Year Ended 30 Septsmber 2025 Icontinued) Group 2025 Dirnct 1.$60 8.126 20.000 Admin Governance Totsl 1.560 8,126 20.000 Publishing ojrrent yearfs conference papers Academic Bursaries Research Grants Bursaries for alterKlees from Wer de¥elope11 ¢￿￿nITieS UKIO 2025 0)nIe￿nCe (note S) 13,653 816,049 13,653 816.049 Support costs 47,086 906.474 2024 Direcl 1.&20 Admin Governar￿ Total 1,620 Publishing yearfs conference pws Academ￿ Bursaries Research Grants Bursaries for attendees from lesser developed Countries UKIO 2024 conferenco Irw)te 5) Supp)rt costs 20.000 5.978 774.474 5,978 774,474 86.903 888.975 47.212 47.212 802,072 39.691 Anatysi* of Support c￿lS 2025 2024 Company wetsfial Finance OffKer horK*awwm Aydrt fees RecTUitrnent fees Directors. and Officets. Insurance Board expenses Bank ¢haryes other administrathve expenses 15,000 6,000 17.865 16.831 5,280 29.009 11,750 2,753 1,340 2,954 1,372 3.327 47.086 86.903 Exp•ndiiur• by th• Group Unltsd Kingdom Imaging and Oncology Cmgras 2025 2024 Direct V￿ue Costs Other Event Cosis Total UKIO Costs 180,905 635.144 816,049 178,905 595,569 774,474 19 RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Statements Forthe Year Ended 30 September 20251Continued) Surplu$ on Ofdlnary Acbvities- Group The surplus ss staled after charging". 2025 2024 Auditorfs remuneration.. AudTt lexduding VAT) NorvA[￿y11 (exduding VAT) 'rectws' aThJ Officers. Insurance 13.500 1.000 2,753 27.394 1.586 2.664 Trustees. Remuneralioii No Trustee received any remunerab"th) during Ihe rjjrrent or pre¥￿tuS year. Travel expenses of £4,16612024.. £7.5691 were re1mbU￿ed lo 8 (2024.. 61 trustees. The Trustees are consdered to be the charty's key managemert personnel. Fixed Asset lThveslments Group investment- cofftpany ROC Events Limrted is a whdly owned subsKJiary by way of a grft of shares. Thè Cl￿PanY'S registered addrès$ is Faimiount Hojse. 230 Tadcaster Road. York. Y024 1 ES. its C¢)mpany ntsmbèr 06722032; il rrEs Out trading activil*s and its pmffts are donated to the parent company. The rA)mpany has aLthorised Share Ca￿al d 1CKI shares at £1 of whth currently only 2 have be*n i￿ued. Company I Charity 2025 2024 Total inveslment The fdlowing inf0m￿kn has been exlrxted from the fmanoal ststements of ROC Events Limited for the year ended 30 September 2025". 2025 2024 A99regale Assets Aggregate Lhabilit Reserves 181094 8T.872 253,693 164,190 Totsl Income Total Expenditwe Profit for year 930.226 836.1106 94.220 901,691 812,190 89.501 20 RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Ststements For the Year Ended 30 September 20251Continued) Dvbtorn Comp*ny I Chaiity 2025 2024 Group 2025 2024 Trade debt¢ys Amounts owed by group un(*rtaknngs Prepayments and accA￿j income VAT re￿Verable 3,317 1.075 26.468 3J21 4.162 61,137 79,458 39.417 119.950 30,289 100.965 118968 As disdosed in rth 13, ROC provths a loan lo ROC Ewits timited in order to pmwde the Latter wilh Working Capital. ROC Events Liml&J runs the anwal UKIO rJ)ryre55. whKh is a ¢haritable aclivty. 10 Curr•nt Ass•t Invmtments Current Asset In¥èsknènts consFSt of bank deposrts wrth a rnaturAy of more than 90 days but less than one year. 11 Credito Ctynpany I Charfty 2025 2024 Group 2025 2024 Trade ¢r¢drtors Defefred Income and Awual$ 50,493 30.170 53.888 29.873 16.373 16,373 19.259 12 Taxation The company is cOnswJ￿d to pass the tests set oul in &h. 6. para. 1 of the Finance Act 2010 and therefore il meets the definrtion of a ¢harita￿e company for UK cwrat¥)n tax purposes. Accordingly. the comp8ny 1$ potenlially exernpt from taxation in fe¥Je¢t of irA*me or caytal gains received within categories cLsvered by Pi. 11, Ch. 3 of the CoyJratM Tax Ad 2010 OT s. 256 of the Taxal￿n of Chargeable Gains Act 1992, lo Ihe ethnt that such wicome or gains a￿ applied exdusively lo charita￿e purposes. 13 Committed Exp¢fiditurn As al 30 September 2025. the Group had entered into contracts for the venue in resped of the 2026, 2027 and 2028 events and wth the ProfessKJnal Conference Organisef in respect of the 2026 event., the total commrtment as of September 30 2025 was £612.65812024." £770.2691. 21 RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Statements For the Year Ended 30 September 20251Continued) 14 R•lat•d Party Transactions On June 2020 the Company 9ranted to it5 sth"diary ROC Events Limited an unserlj￿d loan fa￿lty for an amount of £ScQ.(￿ {ofwhich £26,468 was drawn as at 30 September 20251 repayable on dernand al an interesl rate of 1% plus the Bank of EngL3nd tjase r*e on outstanding balan￿. Inlerest charged on the loan during the year was £4.e65 (2024."£5.7(6). Wth effect from April 1# 2020 the Company seuetan.al fvn￿bjnS for both the Company and its subsidiary ROC Events Lld. a￿ subcontraded to the Instrtute of Physics and En9ineering in Medicine. one ofthe Charity's three members. The 2024r25 fee was £15.CK)01202Y24". £16,831). of wh￿h £3,78012024 - £3.fj80i wa$ unpard as at the year end. 22